🇺🇸 FDA
Patent

US 11173208

Liquid formulation comprising GM-CSF neutralizing compound

granted A61KA61K38/00A61K39/39591

Quick answer

US patent 11173208 (Liquid formulation comprising GM-CSF neutralizing compound) held by TAKEDA GMBH expires Mon Nov 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TAKEDA GMBH
Grant date
Tue Nov 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K38/00, A61K39/39591, A61K47/10, A61K47/183